SCHEMBL8586372

SCHEMBL8586372

NC(=O)Nc1ccc2[nH]cc(/C=C3/C(=O)Nc4ccccc43)c2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 6/20 0.63
PRKD3 O94806 2/20 0.63
ABL1 P00519 2/20 0.63
RET P07949 2/20 0.63
PDGFRB P09619 2/20 0.63
LTK P29376 2/20 0.63
KDR P35968 2/20 0.63
FLT3 P36888 2/20 0.63
CSNK1A1 P48729 2/20 0.63
CDK7 P50613 2/20 0.63
MAP2K1 Q02750 2/20 0.63
MST1R Q04912 2/20 0.63
NTRK3 Q16288 2/20 0.63
NTRK2 Q16620 2/20 0.63
AURKB Q96GD4 2/20 0.63
CLK4 Q9HAZ1 2/20 0.63
ALK Q9UM73 2/20 0.63
DAPK3 O43293 1/20 0.63
MAP4K4 O95819 1/20 0.63
LCK P06239 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8586376 1.00 NTRK1 (0.63) NTRK1PRKD3ABL1RETPDGFRB
SCHEMBL8584113 0.91 NTRK1 (0.61) NTRK1PRKD3ABL1RETPDGFRB
SCHEMBL8584115 0.91 NTRK1 (0.61) NTRK1PRKD3ABL1RETPDGFRB
SCHEMBL8585109 0.88 PAK1 (0.66) NTRK1PRKD3ABL1RETPDGFRB
SCHEMBL8585108 0.88 PAK1 (0.66) NTRK1PRKD3ABL1RETPDGFRB
SCHEMBL8638206 0.84 NTRK1 (0.56) NTRK1PRKD3ABL1RETPDGFRB
SCHEMBL8638214 0.84 NTRK1 (0.56) NTRK1PRKD3ABL1RETPDGFRB
SCHEMBL8320786 0.84 PDK1 (0.47) NTRK1PRKD3ABL1RETPDGFRB
SCHEMBL8586396 0.82 NTRK1 (0.60) NTRK1PRKD3ABL1RETPDGFRB
SCHEMBL8586401 0.82 NTRK1 (0.60) NTRK1PRKD3ABL1RETPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US claimed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 EP claimed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO claimed
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US disclosed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 EP disclosed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO disclosed